JIJIX
Price
$19.84
Change
+$0.18 (+0.92%)
Updated
Jun 2 closing price
Net Assets
5.03B
RERCX
Price
$65.48
Change
+$0.34 (+0.52%)
Updated
Jun 2 closing price
Net Assets
136.57B
Interact to see
Advertisement

JIJIX vs RERCX

Header iconJIJIX vs RERCX Comparison
Open Charts JIJIX vs RERCXBanner chart's image
JIJIX vs RERCX Comparison Chart in %
View a ticker or compare two or three
VS
JIJIX vs. RERCX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JIJIX is a Buy and RERCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RERCX has more cash in the bank: 137B vs. JIJIX (5.03B). RERCX pays higher dividends than JIJIX: RERCX (2.37) vs JIJIX (0.58). JIJIX was incepted earlier than RERCX: JIJIX (7 years) vs RERCX (24 years). RERCX (1.12) is less costly to investors than JIJIX (0.93). JIJIX is a more actively managed with annual turnover of: 135.00 vs. RERCX (35.00). RERCX has a lower initial minimum investment than JIJIX: RERCX (250) vs JIJIX (250000). JIJIX annual gain was more profitable for investors over the last year : 34.44 vs. RERCX (14.14). JIJIX return over 5 years is better than : 24.13 vs. RERCX (-3.51).
JIJIXRERCXJIJIX / RERCX
Total Expense Ratio0.921.1282%
Annual Report Gross Expense Ratio0.931.1283%
Fund Existence7 years24 years-
Gain YTD24.90511.446218%
Front LoadN/AN/A-
Min. Initial Investment250000250100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets5.03B137B4%
Annual Yield % from dividends0.582.3724%
Returns for 1 year34.4414.14244%
Returns for 3 years99.5330.44327%
Returns for 5 years24.13-3.51-688%
Returns for 10 yearsN/A56.24-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STLD271.419.82
+3.75%
Steel Dynamics
COSM0.260.01
+3.33%
Cosmos Health
NWE69.791.56
+2.28%
NorthWestern Energy Group
BBDC8.76-0.08
-0.90%
Barings BDC
RNAC6.41-0.51
-7.37%
Cartesian Therapeutics